ANGIOTENSINOGEN DEPENDENCY OF BLOOD-PRESSURE IN 2 HIGH-RENIN HYPERTENSIVE RAT MODELS

被引：12

作者：

GAHNEM, F ^{[1
]}

VONLUTTEROTTI, N ^{[1
]}

CAMARGO, MJF ^{[1
]}

LARAGH, JH ^{[1
]}

SEALEY, JE ^{[1
]}

机构：

[1] CUMC,CTR CARDIOVASC,DEPT MED,NEW YORK,NY 10021

来源：

AMERICAN JOURNAL OF HYPERTENSION | 1994年 / 7卷 / 10期

关键词：

ANGIOTENSINOGEN; BLOOD PRESSURE; RENIN; LOSARTAN; HYPERTENSION; SHRSP; DAHL S RATS; HIGH-SALT DIET;

D O I：

10.1093/ajh/7.10.899

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

In this analysis we investigated whether angiotensinogen (Aogn) levels were related to blood pressure (BP) in two hypertensive rat models when renin secretion was either under physiologic regulation or out of control. These relationships were investigated using BP data from previous reports in which SHRsp and Dahl S rats were studied for 10 to 12 weeks while ingesting a high-salt diet with and without the angiotensin II (AngII) antagonist losartan. During the first 4 weeks of high-salt diet, plasma renin concentration (PRC) was appropriately suppressed but it subsequently increased paradoxically in both strains. During the first 4 weeks, when renin secretion was under normal control, as indicated by its suppression by the high-salt diet and by an inverse relationship between PRC and BP (r = -0.69, P < .001 and r = -0.53, P < .01 in Dahl S and SHRsp, respectively), there was no relationship between BP and plasma Aogn. In contrast, when renin secretion increased paradoxically, the inverse relationship between NP and PRC was lost and a positive relationship was found between BP and plasma Aogn in both Dahl S rats (r = 0.70, P < .01) and SHRsp (r = 0.57, P < .01). There was no relationship between BP and Aogn in either strain during treatment with losartan either before or after 4 to 6 weeks of salt feeding. These results show Aogn dependency of BP, but only under conditions in which renin cannot feed back normally. The Aogn relationship to BP was most likely dependent on the vasoconstrictor effect of AngII since it was lost during AngII AT1 receptor antagonism.

引用

页码：899 / 904

页数：6

共 22 条

[1] Newton M.A., Sealey J.E., Ledingham J., Laragh J.H., High blood pressure and oral contraceptives. Changes in plasma renin and renin substrate and in aldosterone excretion, Am J Obstetgynecol, 101, pp. 1037-1045, (1968)
[2] Derkx F., Stuenkel C., Schalekamp M., Et al., Im- munoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives, J Clin Endocrinol Metab, 63, pp. 1008-1015, (1986)
[3] Krakoff L.R., Measurement of plasma renin substrate by radioimmunoassay of angiotensin I: Concentration of syndromes associated with steroid excess, J Clin Endocrinol Metab, 37, pp. 110-117, (1973)
[4] Gardes J., Bouhnik J., Clauser E., Et al., Role of angioten- sinogen in blood pressure homeostasis, Hypertension, 4, pp. 185-189, (1982)
[5] Menard J., El Amrani A., Savoie F., Bouhnik J., An- giotensinogen: An attractive and underrated participant in hypertension and inflammation, Hypertension, 18, pp. 705-706, (1991)
[6] Saruta T., Saade G.A., Kaplan N.M., A possible mechanism for hypertension induced by oral contraceptives. Diminished feedback suppression of renin release, Arch Intern Med, 126, pp. 621-626, (1970)
[7] Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., Et al., Molecular basis of human hypertension: Role of angioten- sinogen, Cell, 71, pp. 169-180, (1992)
[8] Walker W.G., Whelton P.K., Saito H., Et al., Relationship between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects, Hypertension, 1, pp. 287-291, (1979)
[9] Volpe M., Camargo M., Mueller F.B., Et al., Relation of plasma renin to end-organ damage and to protection of K + feeding in stroke-prone hypertensive rats, Hypertension, 15, pp. 318-326, (1990)
[10] Camargo M.J., Von Lutterotti N., Campbell W.G., Et al., Control of blood pressure and end-organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade, J Hypertens, 11, pp. 10-31, (1993)

← 1 2 3 →